The largest database of trusted experimental protocols

127 protocols using nisin

1

Quantifying Antimicrobial Activity of Nisin and Lanthipeptides

Check if the same lab product or an alternative is used in the 5 most similar protocols
The activity levels of nisin and new lanthipeptides were determined by a previously described agar diffusion method, with minor modifications.[37] Briefly, a stock nisin solution 1000 IU mL−1) was prepared by adding 50 mg of commercial nisin (106 IU g−1; Sigma‐Aldrich, St. Louis, MO, USA) into 50 mL of sterile 0.02 mol L−1 HCl. Standard nisin solutions of 1000, 500, 250, 200, 100, 20, and 5 IU mL−1 were prepared using the stock solution and diluted with 0.02 mol L−1 HCl to construct a standard curve. The bioassay medium contained 1.2% tryptone, 0.75% yeast extract, 0.75% NaCl, 0.3% NaH2PO4, and 2% agar. After the addition of sterile 0.75% glucose and 0.5% Tween 20, the agar medium was cooled to 50°C and inoculated with 1.5% overnight culture of the indicator strain M. luteus NCIB 8166. The bioassay agar (25 mL) was aseptically poured into sterile Petri dishes, and several holes were made on each plate after solidification. Then, 2 µL of the CFPS mixture supernatant and an equal volume of the nisin Z standard solution were separately added to the holes. After incubation at 30 °C for 18 h, a standard curve of the nisin zone of inhibition versus units of the nisin standard solution was created by measuring the zone diameter using digital calipers (TAJIMA Tool Co., Ltd., Shanghai, China) horizontally and vertically. nisin concentrations for each CFPS mixture were estimated.
+ Open protocol
+ Expand
2

Antimicrobial Peptide Preparation and Formulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
A stock solution of nisin was prepared at 1000 µg/mL by dissolving nisin (1000 UI/mg, 2.5% purity) (Sigma-Aldrich, USA) in 0.02 M HCl (Merck, Germany). A pexiganan stock solution was prepared at 2048 µg/mL by dissolving pexiganan (>95% purity, Innovagen, Sweden) in deionized sterile water. Both nisin and pexiganan stock solutions were filtered using a 0.22 µm filter (Millipore Corporation, Billerica, MA, US) and stored at 4 °C. Working solutions of pexiganan were diluted in water or incorporated within the biogel at concentrations ranging from 1 to 256 µg/mL and incorporated in the collagen model at 256 µg/mL. The dual-AMPs solutions were prepared by supplementing pexiganan solutions with nisin at MIC values, as determined in a previous study by Santos et al. [30 (link)]. Briefly, nisin was added at 12.5 µg/ mL for the dual-AMP suspension in water and at 22.5 µg/mL for the dual-AMP incorporated within the biogel. Working solutions of nisin were diluted in water at a concentration of 12.5 µg/mL, incorporated within the biogel at 22.5 µg/mL and used in the collagen model at 125 µg/mL.
+ Open protocol
+ Expand
3

Standard Nisin Quantification Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The standard nisin (Sigma-Aldrich, St. Louis, MO, USA—containing 2.5% nisin, with 1,000,000 IU/g in its composition) solution was prepared by dissolving 1 g of nisin in 10 mL of phosphate buffer solution (PBS-pH 7.0), as in Table 1. The solution was centrifuged at 13,201 g for 10 min at 10 °C and the supernatant was collected and filtered in a 0.22 µm membrane (Millipore, Burlington, MA, USA). The nisin standard curve was evaluated by an agar diffusion assay. The nisin bioindicator Lactobacillus sakei ATCC 15521 was used for the agar diffusion assay [6 (link),23 (link)].
The concentrations of standard nisin were related by the diameter of the inhibition halo (H, mm), and the activity of nisin was determined and expressed in arbitrary units per mL (AU/mL). The activity of nisin was based on the dilution of the standard nisin calibration curves. The correlation between AU/mL and international units per mL (IU/mL) was 1.09 ± 0.17 AU to 1.0 IU (40 IU = 1 µg of pure nisin A) [14 (link),26 (link)].
+ Open protocol
+ Expand
4

Evaluating Nisin's Cytotoxic Effect on Cancer and Normal Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cytotoxic effect of nisin was evaluated against MCF-7 (a cancerous cell) and HUVEC (a normal cell) cells by MTT [3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide] assay as described previously (26 (link)). In brief, log-phase cells were seeded (1 × 104/well) in 96-well cell culture plates and incubated for overnight. The next day, 20 μL of the prepared concentrations of the produced nisin and commercial nisin (0.39–25 μg.mL-1) was added to each well and incubated for a further 48 h. The standard nisin (Sigma, USA) was dissolved in MRS medium and phosphate buffer saline to evaluate the effect of medium or other interfering materials on cytotoxicity of nisin. Every plate that also had cells treated with MRS medium, PBS and iCSF as negative controls. Cells treated with doxorubicin were used as the positive control. Furthermore, cells were incubated with the combined concentrations of the doxorubicin and nisin (10 μg.mL-1). To evaluate cell viability, cells were incubated with MTT at 37 °C for 3 h. Then, dimethyl sulfoxide (DMSO) was added to dissolve MTT-formazan crystals and the absorbance was measured at 570 nm by a plate reader. The percentage of cell viability was determined according to the following equation:
% Cell survival = Absorbance in drug treated wells / Absorbance in negative control well * 100
+ Open protocol
+ Expand
5

Nisin Preparation and Sterilization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Nisin containing 2.5% active Nisin was purchased from (Sigma Aldrich, UK). Nisin stock solution was prepared with 0.02 mol/L 1 HCl (pH 1.6), and was filter-sterilized through a 0.22 µm disposable sterile syringe filter (Merck, Germany).
+ Open protocol
+ Expand
6

Xylella fastidiosa Strain Cultivation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Xylella fastidiosa subsp. pauca strain A0PT1, isolated from olive trees affected by the olive quick decline syndrome (OQDS) in southern Italy, Apulia region, was used in all experiments. The strain was stored in Pierce disease broth (PD2) (Davis et al., 1980 (link)) supplemented with glycerol (50%) and maintained at −80°C. When needed, aliquots were cultured in buffered charcoal yeast extract (BCYE) (Wells et al., 1981 (link)) agar plates and grown at 28°C for 10 to15 days. Cell suspensions were prepared using phosphate buffered saline (PBS, pH 7.4, 0.01 M) and adjusted to 108 CFU/mL (OD600 ≅ 0.32) (El Handi et al., 2022 (link)). L. lactis subsp. lactis ATCC 11454 was grown on YPGA plates (5.0 g/L yeast extract, 5.0 g/L peptone, 10.0 g/L glucose, and 15.0 g/L agar) for 2 days at 28°C.
Nisin (ITSISLCTPGCKTGALMGCNMKTATCHCSIHVSK), extracted and purified from L. lactis, was purchased from Sigma-Aldrich (Merck KGaA, Darmstadt, Germany). According to the manufacturer, the formulation contains 2.5% (w/w) pure Nisin with potency ≥900 IU/mg. Lyophilized Nisin was solubilized in sterile Milli-Q water to a stock concentration of 12.5 mg/mL and filter sterilized through a 0.22 μm nylon Acrodisc® syringe filter (Merck, Rome, Italy).
+ Open protocol
+ Expand
7

Preparation of Nisin Stock Solution

Check if the same lab product or an alternative is used in the 5 most similar protocols
Nisin with a label activity of 104 International Units (IU/g) was supplied by Sigma-Aldrich Company, UK. Appropriate amount of Nisin was suspended in 0.02 M HCl, centrifuged at 1500 ×g for 20 min; the supernatants were sterilized by 0.22 μm filter (Sigma-Aldrich, UK) and kept at −20°C until use [23 (link)]. To obtain the desired concentration of Nisin, the stock solution was thawed at 25°C and diluted appropriately in sterile water, yielding final concentrations of 250 or 500 IU/mL Nisin.
+ Open protocol
+ Expand
8

Mimicking Bacteriocins and pH Effects

Check if the same lab product or an alternative is used in the 5 most similar protocols
In order to mimic the effect of bacteriocins and reduced pH separately, MAP suspensions were exposed to nisin and solutions of LA. Commercially available nisin (Sigma, St. Louis, MO, United States) was diluted in water and added to the M7H9 media to prepare solutions with final concentrations of 0.1, 1, 10, 100, and 1000 μg of nisin/ml of M7H9. A solution of LA was diluted in M7H9 media to a concentration of 5% (v/v) and the pH was adjusted to 3. This value was chosen with respect to the pH of CFS and previous studies (Klanicova et al., 2012 (link)).
+ Open protocol
+ Expand
9

Polypeptide-Based Antimicrobial Nanomaterials

Check if the same lab product or an alternative is used in the 5 most similar protocols
Poly(vinyl alcohol) (PVA, MW 89–98 kDa, 99+% hydrolysed) and poly(acrylic acid) (PAA, MW 450 kDa), and fluorescamine were purchased from Sigma-Aldrich. Lysozyme (L, from chicken egg white, MW 14.3 kDa, isoelectric point 10.9) and nisin (N, from Lactococcus lactis, MW 3.35 kDa, isoelectric point 8.8) were also acquired to Sigma-Aldrich. nisin impairs bacteria by producing lesions in the cytoplasmic membrane, and Lysozyme hydrolyses the peptidoglycan wall by breaking the β-1,4-glycosidic bonds between N-acetylmuramic acid and N-acetylglucosamine, both resulting in cell lysis.41,42 (link) Ultrapure water (Millipore Milli-Q System) with a resistivity of at least 18 MΩ cm was used in all experiments. The components of culture media and buffers were purchased to Conda-Pronadisa (Spain).
+ Open protocol
+ Expand
10

Nisin Purification and Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Nisin was
purified following a procedure described elsewhere.42 (link) In brief, commercial Nisin (N5764, lyophilized
powder containing ∼2.5% w/w Nisin, Sigma-Aldrich) was dissolved
1.3 g/100 mL in 50 mM sodium lactate acid, pH 3. The Nisin solution
was filtered through 0.45 μm pores and applied to a 5 mL SP
Sepharose fast flow cation exchange column (Sigma-Aldrich). After
a washing step with 50 mL of 600 mM NaCl, purified Nisin was eluted
from the column with the use of 50 mL of 800 mM NaCl. To remove NaCl,
protein in the elution fractions was precipitated with 20% (v/v) trichloroacetic
acid (TCA) overnight at 4 °C. Precipitated protein was washed
twice with ice-cold acetone to remove residual TCA. The purity grade
of Nisin was quantified by HPLC, revealing a purity grade of >95%
(Figures S1 and S2).
Nisin stock
solutions were daily prepared by dissolution of the appropriate protein
amounts in 10 mM phosphate buffer (pH 7.4). In order to help the protein
solubilization, Nisin solutions were subjected to a mild sonication
until clear samples were obtained.43 (link)
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!